APGCS 2020 is Going Virtual

Join us in-person to interact with GI Cancer experts from the Asia-Pacific region and global key opinion leaders assessing and presenting their studies....

CME Applied by Singapore Medical Council

Join us in-person to interact with GI Cancer experts from the Asia-Pacific region and global key opinion leaders assessing and presenting their studies.

Congress begins in

0
Months
:
0
Days
:
0
Hrs
:
0
Mins
:
0
Secs
reserve your seats now

WELCOME MESSAGE

Dear Colleagues and Friends,

On behalf of the Asia Pacific Gastroenterology Cancer Summit (APGCS), we would like to welcome you to Singapore for the 9th edition on 20th & 21st August, 2022 which will be held as LIVE & IN-PERSON event with the sessions being streamed online simultaneously.

With global travel and meeting protocols still very delicate and complex, keeping our community safe in the current situation is top priority, hence, APGCS 2022 will be held in a HYBRID format with the commitment of providing an engaging and memorable experience.

APGCS - a Singaporean grown meeting which started in 2013 has developed into a curated platform for showcasing real world case discussions, breakthrough research and data from the front-line of GI Cancer Care. The success of 2021 virtual meeting with over 16 hours streaming by over 1,300 regional delegates is testimony to its success.

APGCS 2022 will continue to work towards a state of art scientific program and engage audiences with some of the most important and recent discussions via key notes from global leaders, clinical practice experience from regional experts and engaging multidisciplinary tumor boards.

APGCS 2022 will once again take place in conjunction with the International BRCA Forum – iBRCAf 2022.

We welcome you to Singapore to learn and network with your colleagues & peers.

Who Should Attend:


Health Care Professionals in:

  • Gastroenterology
  • Oncology
  • Pathology
  • Hepatology experts
  • Surgeons.
  • Clinical Researchers.
  • Radiologists.
  • General Practioneers.

Main Sponsor 2022

astra
msd1

Gold Sponsors 2022

bristol

Silver Sponsors 2022

DKSH-logo_250x150
Guardant
Ipsen
roche1

Supported by

jsmo
MOS-logo
Myanmar-Oncology-Society
ncsm
PSMO-logo-1
PSGCA-LOGO-1
sso

Meet Our Invited Speakers 2022

reserve your seats now

Twitter

LinkedIn

Early Bird Registration ENDS TODAY! Don't miss to secure your seat for the upcoming 9th Asia-Pacific Gastroenterology Cancer Summit happening on Aug. 20-21, 2022 at the Grand Hyatt, in Singapore!

Register NOW! https://apgcs.com/registration

#apgcs2022 #registration #gicancer

Dr. Iain Tan, APGCS Committee from Singapore, is thrilled to welcome you all to the 9th APGCS happening on Aug. 20-21, 2022!

Join us back in Singapore for THE FIRST HYBRID (Virtual & In-Person) ONCOLOGY MEETING to be held after 2 years!

Prof. Pierce Chow, APGCS Committee from Singapore, is thrilled to welcome you all to the 9th APGCS happening on Aug. 20-21, 2022!

Join us back in Singapore for THE FIRST HYBRID (Virtual & In-Person) ONCOLOGY MEETING to be held after 2 years!

Prof. Toh Han Chong, APGCS Committee from Singapore, is thrilled to welcome you all to the 9th APGCS happening on Aug. 20-21, 2022!

Join us back in Singapore for THE FIRST HYBRID (Virtual & In-Person) ONCOLOGY MEETING to be held after 2 years!

Dr. Shaheenah Dawood, APGCS Committee, is thrilled to welcome you all to the 9th APGCS happening on Aug. 20-21, 2022!

Join us back in Singapore for THE FIRST HYBRID (Virtual & In-Person) ONCOLOGY MEETING to be held after 2 years!

Load More...
Disclaimer:
The 9th Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2022 is a hybrid educational event for Asia Pacific Healthcare professionals. Mention of commercial products, processes, or services throughout the event cannot be construed as an endorsement or recommendation for viewers inside or outside the Asia Pacific Region. Information contained in this event is intended for educational purposes only, you are solely responsible for ensuring compliance with the laws of your specific jurisdiction.